Covered recipient · General Payments record
EMMA E DAMON
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2025
$347.26
- Reported across 7 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $347.26 | 7 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $174.62 | 1 |
| Acerta Pharma LLC | $84.50 | 1 |
| Otsuka America Pharmaceutical, Inc. | $22.56 | 1 |
| Sumitomo Pharma America, Inc. | $21.26 | 1 |
| PFIZER INC. | $17.13 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $15.69 | 1 |
| CeQur Corporation | $11.50 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $347.26 | 7 |
Payment records · PY2025 (7)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $84.50 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1206386420 | CMS |
| CeQur Corporation | $11.50 | 11/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228226368 | CMS |
| Medtronic, Inc. | $174.62 | 10/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1218893028 | CMS |
| Novartis Pharmaceuticals Corporation | $15.69 | 11/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1200025601 | CMS |
| Otsuka America Pharmaceutical, Inc. | $22.56 | 10/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227315459 | CMS |
| PFIZER INC. | $17.13 | 10/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1229217939 | CMS |
| Sumitomo Pharma America, Inc. | $21.26 | 11/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1176632580 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.